Skip to main content
78°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Xenon Pharmaceuticals Inc. - Common Shares
(NQ:
XENE
)
36.92
+2.81 (+8.25%)
Streaming Delayed Price
Updated: 10:25 AM EDT, Aug 12, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Xenon Pharmaceuticals Inc. - Common Shares
< Previous
1
2
3
4
5
6
7
Next >
Xenon Reports Second Quarter 2025 Financial Results & Business Update
August 11, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
A Look Ahead: Xenon Pharmaceuticals's Earnings Forecast
August 08, 2025
Via
Benzinga
Xenon to Report Q2 2025 Financial Results on August 11, 2025
August 04, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Earnings Scheduled For May 12, 2025
May 12, 2025
Via
Benzinga
What to Expect from Xenon Pharmaceuticals's Earnings
May 09, 2025
Via
Benzinga
Earnings Scheduled For August 11, 2025
August 11, 2025
Via
Benzinga
Biogen Shares Slip After $46M Research Charge Hits Quarterly Profit
July 07, 2025
The company anticipates a research expense in Q2 associated with milestone and licensing payments, which will impact both GAAP and non-GAAP earnings per share.
Via
Stocktwits
Xenon Joins the Russell 3000® and Russell 2000® Indexes
June 27, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 26, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Earnings Scheduled For February 27, 2025
February 27, 2025
Via
Benzinga
Xenon Announces Appointment of Darren Cline as Chief Commercial Officer
June 24, 2025
Mr. Cline brings extensive commercial expertise to lead the transition of Xenon to a commercial-stage company with the anticipated launch of azetukalner across three potential indications
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
June 03, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 30, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference
May 14, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Crude Oil Gains 3%; US Inflation Eases In April
May 13, 2025
Via
Benzinga
Topics
Economy
Xenon Reports First Quarter 2025 Financial Results and Provides Business Update
May 12, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
This Discover Financial Services Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
May 07, 2025
Via
Benzinga
This Waste Connections Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
May 07, 2025
Via
Benzinga
Xenon to Report Q1 2025 Financial Results on May 12, 2025
May 05, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 02, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025
April 04, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon to Present at Stifel 2025 Virtual CNS Forum
March 12, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update
February 27, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon to Present at the 45th Annual TD Cowen Healthcare Conference
February 25, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon to Report Q4 and Full Year 2024 Financial Results on February 27, 2025
February 20, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Outlines Key Corporate Milestone Opportunities for 2025
January 13, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 07, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024
December 06, 2024
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Xenon to Showcase New Long-Term Azetukalner Data at AES 2024
November 25, 2024
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
